U.S. Veterinary Orthobiologics Market Size & Outlook
Related Markets
U.S. veterinary orthobiologics market highlights
- The U.S. veterinary orthobiologics market generated a revenue of USD 255.2 million in 2023 and is expected to reach USD 434.7 million by 2030.
- The U.S. market is expected to grow at a CAGR of 7.9% from 2024 to 2030.
- In terms of segment, platelet-rich plasma (prp) was the largest revenue generating product in 2023.
- Other Biologics is the most lucrative product segment registering the fastest growth during the forecast period.
Veterinary orthobiologics market data book summary
| Market revenue in 2023 | USD 255.2 million |
| Market revenue in 2030 | USD 434.7 million |
| Growth rate | 7.9% (CAGR from 2023 to 2030) |
| Largest segment | Platelet-rich plasma (prp) |
| Fastest growing segment | Other Biologics |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Stem Cells, Platelet-Rich Plasma (PRP), Other Biologics |
Other key industry trends
- In terms of revenue, U.S. accounted for 37.0% of the global veterinary orthobiologics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. veterinary orthobiologics market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 45.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Veterinary Orthobiologics Market Scope
Veterinary Orthobiologics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Movora | View profile | 251-500 | Saint Augustine, Florida, United States, North America | https://movora.com |
| Enso Discoveries | View profile | 1-10 | Manhattan, Kansas, United States, North America | https://www.ensodiscoveries.com |
| Medrego | View profile | 1-10 | Riga, Riga, Latvia, Europe | https://www.medrego.com/ |
| Ardent Health Services | View profile | 10001+ | Nashville, Tennessee, United States, North America | http://ardenthealth.com |
| Arthrex | View profile | 5001-10000 | Naples, Florida, United States, North America | https://www.arthrex.com/ |
| Enovis Corp | View profile | 6550 | 2711 Centerville Road, Suite 400, Wilmington, DE, United States, 19808 | https://www.enovis.com |
| Dechra Pharmaceuticals | View profile | 501-1000 | Northwich, Cheshire, United Kingdom, Europe | http://www.dechra.com |
| Boehringer Ingelheim | View profile | 10001+ | Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe | https://www.boehringer-ingelheim.com/ |
| Zoetis Inc Class A | View profile | 14100 | 10 Sylvan Way, Parsippany, NJ, United States, 07054 | https://www.zoetis.com |
U.S. veterinary orthobiologics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary orthobiologics market will help companies and investors design strategic landscapes.
Platelet-rich plasma (prp) was the largest segment with a revenue share of 38.99% in 2023. Horizon Databook has segmented the U.S. veterinary orthobiologics market based on stem cells, platelet-rich plasma (prp), other biologics covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to U.S. veterinary orthobiologics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. veterinary orthobiologics market databook
-
Our clientele includes a mix of veterinary orthobiologics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. veterinary orthobiologics market , including forecasts for subscribers. This country databook contains high-level insights into U.S. veterinary orthobiologics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. veterinary orthobiologics market size, by product, 2018-2030 (US$M)
U.S. Veterinary Orthobiologics Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
